Friday, Oct 23, 2026
Focus on the big picture

AstraZeneca sees higher 2022 sales, but COVID boost waning

Reuters, 10 Feb 2022
AstraZeneca forecast higher 2022 sales and raised its annual dividend for the first time in a decade, but warned that the boost from COVID-19 products would fall.

#AstraZeneca #COVID #News #Reuters

Subscribe: http://smarturl.it/reuterssubscribe

Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
Related Articles